Sandoz - PharmaVitae Generics Profile

This analysis examines the historical and forecast performance for Sandoz in the generic pharmaceutical sector. The profile encompasses global company strategy, generic and biosimilar portfolio and pipeline analysis and assessment of financial performance. An interactive data and analysis tool provides quantitative and qualitative information.

Key reasons to read this report

Benchmark Sandoz's performance against key rivals in the generic pharmaceutical sector
Evaluate Sandoz's historical and forecast generic growth drivers and resistors
Understand the strategy behind Sandoz's recent launch of its first biosimilar, Omnitrope

For more information, please visit :
http://www.bharatbook.com/detail.asp?id=50853